D-0573-2022 Class II Ongoing

Recalled by RISING PHARMACEUTICALS — East Brunswick, NJ

Recall Details

Product Type
Drugs
Report Date
March 2, 2022
Initiation Date
February 7, 2022
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2220 100-count bottles

Product Description

Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., Saddle Brook, NJ 07863, NDC 64980-221-01

Reason for Recall

Failed Tablet Specifications: Recall of this drug product was voluntarily initiated by the manufacturer due to a market complaint, which stated that a tablet in the sealed bottle was twice larger in size when compared to the remaining tablets. This complaint is second of its kind.

Distribution Pattern

Nationwide in the USA

Code Information

lot# 25910009, Exp 01/2023